1. Home
  2. MG vs CSTL Comparison

MG vs CSTL Comparison

Compare MG & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mistras Group Inc

MG

Mistras Group Inc

N/A

Current Price

$20.21

Market Cap

642.4M

ML Signal

N/A

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

N/A

Current Price

$34.00

Market Cap

722.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MG
CSTL
Founded
1978
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
642.4M
722.8M
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
MG
CSTL
Price
$20.21
$34.00
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
$21.18
★ $48.20
AVG Volume (30 Days)
347.1K
★ 375.3K
Earning Date
11-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.51
N/A
Revenue
★ $700,970,000.00
$344,229,000.00
Revenue This Year
$3.15
$12.74
Revenue Next Year
$5.40
$11.78
P/E Ratio
$39.63
★ N/A
Revenue Growth
N/A
★ 3.66
52 Week Low
$11.13
$17.72
52 Week High
$21.92
$44.28

Technical Indicators

Market Signals
Indicator
MG
CSTL
Relative Strength Index (RSI) 43.61 46.78
Support Level $20.06 $31.64
Resistance Level $21.77 $34.23
Average True Range (ATR) 0.11 2.01
MACD -0.04 -0.17
Stochastic Oscillator 30.61 25.16

Price Performance

Historical Comparison
MG
CSTL

About MG Mistras Group Inc

MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International, and Products and Systems, of which key revenue is derived from the North America segment. The North America segment provides asset protection solutions, including NDT, inspection, and mechanical and engineering services, along with software, digital, and data services.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: